Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.52)
# 251
Out of 5,157 analysts
563
Total ratings
51.86%
Success rate
22.39%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $18.24 | +102.85% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $14.93 | +33.96% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.32 | +115.52% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $544.71 | -8.21% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $190.48 | +1.85% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.79 | +54.04% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.10 | +350.98% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $81.52 | -26.40% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $21.97 | +45.65% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $492.38 | +11.70% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $139.40 | -13.92% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $6.29 | +27.19% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.53 | -63.83% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $38.56 | -9.23% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.58 | +46.14% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $37.94 | -7.75% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $6.03 | +132.17% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $58.20 | +28.87% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $19.99 | +90.10% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $11.27 | +121.83% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $21.61 | +48.08% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.49 | +253.36% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $20.71 | -22.74% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $13.48 | +78.04% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.06 | +292.16% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $139.69 | -72.80% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $129.54 | +29.69% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $3.37 | +226.41% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.96 | +237.84% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $14.08 | +56.25% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $24.54 | -18.50% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.81 | +562.98% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.65 | +130.09% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.55 | +28.65% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.60 | +310.71% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.15 | +1,204.35% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $24.41 | +43.41% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $10.43 | +619.08% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.99 | +134.11% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.21 | +352.49% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.64 | +23,410.97% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $16.37 | +266.52% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.94 | +203.64% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.79 | +4,982.59% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $18.24
Upside: +102.85%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $14.93
Upside: +33.96%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.32
Upside: +115.52%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $544.71
Upside: -8.21%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $190.48
Upside: +1.85%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.79
Upside: +54.04%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.10
Upside: +350.98%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $81.52
Upside: -26.40%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $21.97
Upside: +45.65%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $492.38
Upside: +11.70%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $139.40
Upside: -13.92%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $6.29
Upside: +27.19%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.53
Upside: -63.83%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $38.56
Upside: -9.23%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.58
Upside: +46.14%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $37.94
Upside: -7.75%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $6.03
Upside: +132.17%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $58.20
Upside: +28.87%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $19.99
Upside: +90.10%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $11.27
Upside: +121.83%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $21.61
Upside: +48.08%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.49
Upside: +253.36%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $20.71
Upside: -22.74%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $13.48
Upside: +78.04%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.06
Upside: +292.16%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $139.69
Upside: -72.80%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $129.54
Upside: +29.69%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $3.37
Upside: +226.41%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $2.96
Upside: +237.84%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.08
Upside: +56.25%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $24.54
Upside: -18.50%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.81
Upside: +562.98%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.65
Upside: +130.09%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.55
Upside: +28.65%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.60
Upside: +310.71%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.15
Upside: +1,204.35%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $24.41
Upside: +43.41%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $10.43
Upside: +619.08%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.99
Upside: +134.11%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.64
Upside: +23,410.97%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $16.37
Upside: +266.52%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.94
Upside: +203.64%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.79
Upside: +4,982.59%